Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Sep;49(1):52–63. doi: 10.1111/j.1476-5381.1973.tb08267.x

Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase

R W Horton, B S Meldrum
PMCID: PMC1776427  PMID: 4207045

Abstract

1. DL-C-Allyglycine, 4-deoxypyridoxine hydrochloride and 3-mercaptopropionic acid have been studied with reference to their convulsant effects in mice and in baboons (Papio papio) with photosensitive epilepsy, and their action on the cerebral enzyme synthesizing γ-aminobutyric acid (L-glutamate-1-carboxy-lyase).

2. In mice, the ED50 values for seizures following intraperitoneal injection were allylglycine 1·0 mmol/kg body weight, 4-deoxypyridoxine 1·1 mmol/kg and 3-mercaptopropionic acid 0·27 mmol/kg. Latency to seizure onset was longest after allylglycine (44-240 min), intermediate after 4-deoxypyridoxine (9-114 min) and shortest after 3-mercaptopropionic acid (2·5-8 min).

3. In Papio papio intravenous administration of subconvulsant doses of allylglycine (0·87-3·1 mmol/kg), or of 4-deoxypyridoxine (0·21-0·53 mmol/kg) enhanced the occurrence and persistence of myoclonic responses to intermittent photic stimulation, and augmented the associated electroencephalographic abnormalities, without modifying their character or distribution. Higher doses produced brief seizures recurring at regular intervals, between 2-14 h after allylglycine (4·0-4·3 mmol/kg) or 1-4 h after 4-deoxypyridoxine (0·53-0·87 mmol/kg). Electroencephalographically these seizures originated unilaterally in the occipital or posterior parietal cortex.

4. In Papio papio photically-induced epileptic responses were enhanced 5-10 min after the intravenous injection of 3-mercaptopropionic acid (0·09-0·28 mmol/kg). A sequence of brief generalized seizures followed by complete recovery occurred 4-17 min after the injection of 3-mercaptopropionic acid (0·28-0·38 mmol/kg). Fatal status epilepticus followed the injection of 3-mercaptopropionic acid (0·57-0·75 mmol/kg). E.E.G. records showed generalized cortical involvement at the onset of the seizures.

5. L-Glutamate 1-carboxy-lyase (GAD) activity was determined in whole brain homogenates from mice killed at various intervals after receiving i.p. a convulsant dose of one of the compounds. Inhibition of GAD activity was evident 30-60 min before seizure onset following allylglycine or 4-deoxypyridoxine administration, and was maximal (40-60%) just before or during seizure activity. Addition of pyridoxal phosphate to the brain homogenate relieved inhibition produced by 4-deoxypyridoxine but not that produced by allylglycine. Inhibition of GAD activity in brain homogenates from animals killed 2 or 4 min after injection of a convulsant dose of 3-mercaptopropionic acid varied from 0-49% depending on the dose of 3-mercaptopropionic acid and the concentration of substrate in the assay system.

6. Kinetic analysis of the inhibition of GAD activity following direct addition of the compounds to mouse brain homogenates indicated that 3-mercaptopropionic acid (0.01-0.5 mM) was competitive with respect to the substrate. A comparable percentage inhibition of GAD activity was obtained only with much higher concentrations of 4-deoxypyridoxne, i.e. 10-50 mM. Allylglycine in vitro was a very weak inhibitor of GAD activity.

7. Three biochemically different mechanisms underlie the inhibition of cerebral GAD activity that precedes seizures induced by ailylglycine, 4-deoxypyridoxine and 3-mercaptopropionic acid. The data are consistent with a critical reduction in the rate of synthesis of γ-aminobutyric acid being responsible for the onset of seizures.

Full text

PDF
52

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberici M., Rodriguez de Lores Arna, De Robertis E. Glutamic acid decarboxylase inhibition and ultrastructural changes by the convulsant drug allylglycine. Biochem Pharmacol. 1969 Jan;18(1):137–143. doi: 10.1016/0006-2952(69)90018-5. [DOI] [PubMed] [Google Scholar]
  2. Curtis D. R., Duggan A. W., Felix D., Johnston G. A. Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res. 1971 Sep 10;32(1):69–96. doi: 10.1016/0006-8993(71)90156-9. [DOI] [PubMed] [Google Scholar]
  3. Curtis D. R., Duggan A. W., Felix D., Johnston G. A., McLennan H. Antagonism between bicuculline and GABA in the cat brain. Brain Res. 1971 Oct 8;33(1):57–73. doi: 10.1016/0006-8993(71)90305-2. [DOI] [PubMed] [Google Scholar]
  4. Davidson N., Southwick C. A. Amino acids and presynaptic inhibition in the rat cuneate nucleus. J Physiol. 1971 Dec;219(3):689–708. doi: 10.1113/jphysiol.1971.sp009683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. De Canal M. A., De Lores Arnaiz G. R. Inhibition of protein synthesis in brain subcellular fractions by the convulsant allylglycine. Biochem Pharmacol. 1972 Jan;21(1):133–136. doi: 10.1016/0006-2952(72)90262-6. [DOI] [PubMed] [Google Scholar]
  6. Duggan A. W., McLennan H. Bicuculline and inhibition in the thalamus. Brain Res. 1971 Jan 8;25(1):188–191. doi: 10.1016/0006-8993(71)90579-8. [DOI] [PubMed] [Google Scholar]
  7. HOLTZ P., PALM D. PHARMACOLOGICAL ASPECTS OF VITAMIN B6. Pharmacol Rev. 1964 Jun;16:113–178. [PubMed] [Google Scholar]
  8. KILLAM K. F., BAIN J. A. Convulsant hydrazides. I. In vitro and in vivo inhibition of vitamin B6 enzymes by convulsant hydrazides. J Pharmacol Exp Ther. 1957 Feb;119(2):255–262. [PubMed] [Google Scholar]
  9. KILLAM K. F. Convulsant hydrazides. II. Comparison of electrical changes and enzyme inhibition induced by the administration of thiosemicarbazide. J Pharmacol Exp Ther. 1957 Feb;119(2):263–271. [PubMed] [Google Scholar]
  10. Krnjević K., Randić M., Straughan D. W. An inhibitory process in the cerebral cortex. J Physiol. 1966 May;184(1):16–48. doi: 10.1113/jphysiol.1966.sp007902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Krnjević K., Randić M., Straughan D. W. Pharmacology of cortical inhibition. J Physiol. 1966 May;184(1):78–105. doi: 10.1113/jphysiol.1966.sp007904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LEHMANN A. CONTRIBUTION A L''ETUDE PSYCHOPHYSIOLOGIQUE ET NEUROPHARMACOLOGIQUE DE L'EPILEPSIE ACOUSTIQUE DE LA COURIS ET DU RAT. II. ETUDE EXP'ERIMENTALE. Agressologie. 1964 Jul-Aug;5:311–CONTD. [PubMed] [Google Scholar]
  13. Lamar C., Jr Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J Neurochem. 1970 Feb;17(2):165–170. doi: 10.1111/j.1471-4159.1970.tb02197.x. [DOI] [PubMed] [Google Scholar]
  14. Meldrum B. S., Balzano E., Gadea M., Naquet R. Photic and drug-induced epilepsy in the baboon (Papio papio): the effects of isoniazid, thiosemicarbazide, pyridoxine and amino-oxyacetic acid. Electroencephalogr Clin Neurophysiol. 1970 Oct;29(4):333–347. doi: 10.1016/0013-4694(70)90041-6. [DOI] [PubMed] [Google Scholar]
  15. Meldrum B. S., Horton R. W. Convulsive effects of 4-deoxypyridoxine and of bicuculline in photosensitive baboons (Papio papio) and in rhesus monkeys (Macaca mulatta). Brain Res. 1971 Dec 24;35(2):419–436. doi: 10.1016/0006-8993(71)90485-9. [DOI] [PubMed] [Google Scholar]
  16. PFEIFFER C. C., JENNEY E. H., MARSHALL W. H. Experimental seizures in man and animals with acute pyridoxine deficiency produced by hydrazides. Electroencephalogr Clin Neurophysiol. 1956 May;8(2):307–315. doi: 10.1016/0013-4694(56)90122-5. [DOI] [PubMed] [Google Scholar]
  17. ROBERTS E., SIMONSEN D. G. Some properties of L-glutamic decarboxylase in mouse brain. Biochem Pharmacol. 1963 Feb;12:113–134. doi: 10.1016/0006-2952(63)90177-1. [DOI] [PubMed] [Google Scholar]
  18. Roper S. Inhibition of Mauthner cells by allylglycine. Nature. 1970 Apr 25;226(5243):373–374. doi: 10.1038/226373a0. [DOI] [PubMed] [Google Scholar]
  19. Tapia R., Awapara J. Effects of various substituted hydrazones and hydrazines of pyridoxal-5'-phosphate on brain glutamate decarboxylase. Biochem Pharmacol. 1969 Jan;18(1):145–152. doi: 10.1016/0006-2952(69)90019-7. [DOI] [PubMed] [Google Scholar]
  20. Tapia R., Pérez de la Mora M., Massieu G. H. Correlative changes of pyridoxal kinase pyridoxal-5'-phosphate and glutamate decarboxylase in brain, during drug-induced convulsions. Ann N Y Acad Sci. 1969 Sep 30;166(1):257–266. doi: 10.1111/j.1749-6632.1969.tb54276.x. [DOI] [PubMed] [Google Scholar]
  21. Wood J. D., Abrahams D. E. The comparative effects of various hydrazides on -aminobutyric acid and its metabolism. J Neurochem. 1971 Jun;18(6):1017–1025. doi: 10.1111/j.1471-4159.1971.tb12031.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES